| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.059 | 0.5 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |